Wall Street Journal Examines How Costly Cancer Drugs Affect Physicians' Treatment Decisions

 09.07.2008 16:17   medicalnewstoday.com

The Wall Street Journal on Tuesday examined how "hyperexpensive cancer drugs" are causing oncologists to go into debt and potentially interfering with treatment decisions. According to the Journal, a "new generation of cancer drugs," including Genentech's Avastin and

World Cancer